Summit Therapeutics (SMMT) Revenue: 2016-2024
Historic Revenue for Summit Therapeutics (SMMT) over the last 7 years, with Q2 2024 value amounting to -$3.1 million.
- Summit Therapeutics' Revenue changed N/A to -$3.1 million in Q2 2024 from the same period last year, while for Sep 2025 it was -$0.0, marking a year-over-year increase of 10000.0%. This contributed to the annual value of $705000.0 for FY2022, which is 6102.82% down from last year.
- Per Summit Therapeutics' latest filing, its Revenue stood at -$3.1 million for Q2 2024.
- Over the past 5 years, Summit Therapeutics' Revenue peaked at $324311.9 during Q1 2020, and registered a low of -$3.1 million during Q1 2024.
- Over the past 3 years, Summit Therapeutics' median Revenue value was -$1.4 million (recorded in 2022), while the average stood at -$1.4 million.
- Examining YoY changes over the last 5 years, Summit Therapeutics' Revenue showed a top increase of 3357.02% in 2020 and a maximum decrease of 3357.02% in 2020.
- Over the past 3 years, Summit Therapeutics' Revenue (Quarter) stood at $324311.9 in 2020, then plummeted by 32.16% to $220000.0 in 2022, then tumbled by 1510.0% to -$3.1 million in 2024.
- Its last three reported values are -$3.1 million in Q2 2024, -$3.1 million for Q1 2024, and $220000.0 during Q3 2022.